AIMC Topic: Humans

Clear Filters Showing 18281 to 18290 of 95995 articles

FMI-CAECD: Fusing Multi-Input Convolutional Features with Enhanced Channel Attention for Cardiovascular Diseases Prediction.

Sensors (Basel, Switzerland)
Cardiovascular diseases (CVD) have become a major public health problem affecting the national economy and social development, and have become one of the major causes of death. Therefore, the prevention, control and risk assessment of CVD have been i...

Advanced Low-Cost Technology for Assessing Metal Accumulation in the Body of a Metropolitan Resident Based on a Neural Network Model.

Sensors (Basel, Switzerland)
This study is devoted to creating a neural network technology for assessing metal accumulation in the body of a metropolis resident with short-term and long-term intake from anthropogenic sources. Direct assessment of metal retention in the human bod...

A Multi-Scale CNN for Transfer Learning in sEMG-Based Hand Gesture Recognition for Prosthetic Devices.

Sensors (Basel, Switzerland)
Advancements in neural network approaches have enhanced the effectiveness of surface Electromyography (sEMG)-based hand gesture recognition when measuring muscle activity. However, current deep learning architectures struggle to achieve good generali...

Machine Learning Algorithms to Estimate Propensity Scores in Health Policy Evaluation: A Scoping Review.

International journal of environmental research and public health
(1) Background: Quasi-experimental design has been widely used in causal inference for health policy impact evaluation. However, due to the non-randomized treatment used, there is great potential for bias in the assessment of the results, which can b...

Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry.

Scientific reports
Clinical risk scores that predict outcomes in patients with atrial fibrillation (AF) have modest predictive value. Machine learning (ML) may achieve greater results when predicting adverse outcomes in patients with recently diagnosed AF. Several ML m...

Artificial intelligence-based prediction of neurocardiovascular risk score from retinal swept-source optical coherence tomography-angiography.

Scientific reports
The recent rise of artificial intelligence represents a revolutionary way of improving current medical practices, including cardiovascular (CV) assessment scores. Retinal vascular alterations may reflect systemic processes such as the presence of CV ...

Leveraging large-scale Mycobacterium tuberculosis whole genome sequence data to characterise drug-resistant mutations using machine learning and statistical approaches.

Scientific reports
Tuberculosis disease (TB), caused by Mycobacterium tuberculosis (Mtb), is a major global public health problem, resulting in > 1 million deaths each year. Drug resistance (DR), including the multi-drug form (MDR-TB), is challenging control of the dis...

Prediction of viral oncoproteins through the combination of generative adversarial networks and machine learning techniques.

Scientific reports
Viral oncoproteins play crucial roles in transforming normal cells into cancer cells, representing a significant factor in the etiology of various cancers. Traditionally, identifying these oncoproteins is both time-consuming and costly. With advancem...

Cross-instrument optical coherence tomography-angiography (OCTA)-based prediction of age-related macular degeneration (AMD) disease activity using artificial intelligence.

Scientific reports
This study investigates the efficacy of predicting age-related macular degeneration (AMD) activity through deep neural networks (DNN) using a cross-instrument training dataset composed of Optical coherence tomography-angiography (OCTA) images from tw...

In silico formulation optimization and particle engineering of pharmaceutical products using a generative artificial intelligence structure synthesis method.

Nature communications
Pharmaceutical drug dosage forms are critical for ensuring the effective and safe delivery of active pharmaceutical ingredients to patients. However, traditional formulation development often relies on extensive lab and animal experimentation, which ...